Indrayani Biotech

quarterly
yearly
ParticularsMar '23Jun '23Sep '23Dec '23Mar '24
Revenue21.4516.8316.1013.7719.25
Expenses20.5816.1115.7013.5117.62
EBITDA2.602.041.391.414.45
EBIT2.111.681.031.044.09
Profit Before Tax0.870.720.410.261.62
Net Profit0.870.720.410.260.07
Financial Ratios
Operating Profit Margin12.21%12.13%8.68%10.30%28.16%
Net Profit Margin4.08%4.28%2.56%1.90%0.44%
Earning Per Share (Diluted)0.240.200.110.060.08
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.1.5
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ